BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26121863)

  • 1. [The Methylation of p16 Gene Promoter in Carcinogenesis and Development of Breast Cancer].
    Zhang YB; Lu HX; Zhang XR; Qin LJ; Dong GL; Sun N; Zhang T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):409-12. PubMed ID: 26121863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methylation and expression of gene p16INK4a and RB in breast carcinoma].
    Zhao YF; Shen SP; Jiang JY; Geng H; Guo JG; Xie LP
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):377-81. PubMed ID: 21055153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
    Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
    J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between methylation of p16 INK 4/CDKN2 gene in promoter region and progress of squamous cell carcinoma of buccal mucosa].
    Dong YY; Wang J; Dong FS; Wang X; Li HX; Gu HT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 May; 41(5):297-8. PubMed ID: 16784614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: clinical implications.
    Hu XC; Wong IH; Chow LW
    Oncol Rep; 2003; 10(6):1811-5. PubMed ID: 14534701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients.
    Erdem B; Küçükyıldırım S; Sağlar E; Polat Z; Mergen H
    Turk J Gastroenterol; 2014 Oct; 25(5):512-7. PubMed ID: 25417611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abnormality of p16 gene and its clinicopathological significance in non-small cell lung cancer].
    Fu J; Zhang J; Zhang HW
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):133-6. PubMed ID: 12839675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 promoter methylation, expression, and its association with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 subtype of breast carcinoma.
    Goyal A; Sahu RK; Kumar M; Sharma S; Qayyum S; Kaur N; Singh UR; Mehrotra R; Hedau S
    J Cancer Res Ther; 2019; 15(5):1147-1154. PubMed ID: 31603125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
    Bean GR; Bryson AD; Pilie PG; Goldenberg V; Baker JC; Ibarra C; Brander DM; Paisie C; Case NR; Gauthier M; Reynolds PA; Dietze E; Ostrander J; Scott V; Wilke LG; Yee L; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Tlsty TD; Seewaldt VL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6834-41. PubMed ID: 18006786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16(INK4a) promoter methylation and protein expression in breast fibroadenoma and carcinoma.
    Di Vinci A; Perdelli L; Banelli B; Salvi S; Casciano I; Gelvi I; Allemanni G; Margallo E; Gatteschi B; Romani M
    Int J Cancer; 2005 Apr; 114(3):414-21. PubMed ID: 15578730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
    Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
    Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
    Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
    BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
    Fang HL; Yu ZC; Zhu HB; Jin YT
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues.
    Llanos AA; Dumitrescu RG; Brasky TM; Liu Z; Mason JB; Marian C; Makambi KH; Spear SL; Kallakury BV; Freudenheim JL; Shields PG
    Carcinogenesis; 2015 Jan; 36(1):60-7. PubMed ID: 25344837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue.
    Celebiler Cavusoglu A; Sevinc AI; Saydam S; Canda T; Baskan Z; Kilic Y; Sakizli M
    Neoplasma; 2010; 57(5):465-72. PubMed ID: 20568901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between methylation of the p16 promoter and cervical cancer incidence.
    Wang FL; Yang Y; Liu ZY; Qin Y; Jin T
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2351-2356. PubMed ID: 28617556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer.
    Vallian S; Sedaghat M; Nassiri I; Frazmand A
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):991-6. PubMed ID: 19125298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.